BioTelemetry (NASDAQ: BEAT) reported Q1 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $42.7 million versus the consensus estimate of $40.95 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.